This is an old revision of the document!


Chronic Progressive External Ophthalmoplegia

abbreviated CPEO

Feature CPEO CFEOM
Nature of disorder Mitochondrial myopathy of extraocular muscle Congenital cranial dysinnervation disorder (neurogenic; abnormal CN III/IV/VI development with secondary muscle fibrosis)
Onset Adult, typically 18–40 yrs; ptosis first sign Congenital / present at birth
Course Slowly progressive over years Non-progressive (rare exceptions)
Symmetry / gaze Generally symmetric, diffuse limitation of all directions; superior rectus often prominently involved Fixed characteristic pattern — CFEOM1: eyes fixed in infraduction, absent upgaze; CFEOM2: large-angle exotropia
Ptosis Common, may be uni- or bilateral, progressive Congenital, typically bilateral; chin-up head posture
Diplopia Usually absent (<30%) due to gradual symmetric onsetAbsent; binocular vision typically never develops
Pupils Spared Spared in CFEOM1; poorly reactive in CFEOM2
Inheritance / genetics Single large-scale mtDNA deletion (~50%, sporadic); also nuclear mtDNA-maintenance genes (POLG, RRM2B, TWNK) and mtDNA point mutations Mendelian: CFEOM1 (AD, KIF21A); CFEOM2 (AR, PHOX2A); CFEOM3 (AD, TUBB3/TUBB2B/TUBA1A/KIF21A)
Systemic/associated features “CPEO-plus”: retinopathy, ataxia, neuropathy, deafness, cardiac conduction block, diabetes (Kearns-Sayre) Usually isolated; CFEOM3 may have developmental/CNS anomalies (e.g., Tukel syndrome)
Muscle biopsy Ragged-red / COX-negative fibers; mitochondrial abnormalities Not a mitochondrial biopsy diagnosis; muscle shows fibrosis/denervation changes
Orbital MRI Mild EOM atrophy with fatty/spongiform T1 signal EOM hypoplasia + hypoplastic ocular motor nerves